5 September 2024 - Perspective Therapeutics today announced that the US FDA granted fast track designation for the development of ...
27 August 2024 - TruSight Oncology Comprehensive is the first US FDA approved, distributable comprehensive genomic profiling Iin vitro diagnostic kit ...
28 August 2024 - Life Molecular Imaging is pleased to announce that the US FDA granted fast track designation to [18F]PI-2620 ...
28 August 2024 - Telix today announces it has submitted a new drug application to the US FDA for TLX101-CDx, (Pixclara, ...
22 August 2024 - Clarity Pharmaceuticals is pleased to announce that the US FDA has granted fast track designation for 64Cu-SAR-bisPSMA ...
5 August 2024 - A Phase 3 study for 124I-evuzamitide in patients with suspected cardiac amyloidosis is anticipated to begin ...
1 August 2024 - Polarean Imaging announces that it has submitted a new drug application supplement to the US FDA to ...
1 August 2024 - FDA approval announced earlier this week makes Shield first blood test that is approved for primary screening ...
23 July 2024 - Telix today announces that the US FDA has accepted the filing of its new drug application for ...
1 July 2024 - For the first time, IQWiG has evaluated a drug that is a diagnostic agent within the ...
3 June 2024 - Telix today announces that it has completed the submission of a biologics license application to the ...
27 May 2024 - Telix Pharmaceuticals today announces it has submitted a new drug application to the US FDA for ...
18 April 2024 - Lumisight and Lumicell DVS previously received FDA fast track and breakthrough device designations, respectively. ...
16 April 2024 - Telix Pharmaceuticals today announces that the US FDA has granted fast track designation for the Company's investigational ...
22 February 2024 - Curium announced today that the marketing authorisation application for Pylclari (piflufolastat (18F)) submitted by exclusive Swiss ...